SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 112.70 thousand shares for the 6-month period ending 2020-09-30, per its 10-Q filed 2020-11-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2020-11-20
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 8.70K shares, a 73.94% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-06-30 was 104.00K shares, a 5100.00% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2019-09-30 was 5.00K shares, a 82.14% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2016 was 190.00K shares, a 341.86% increase from fiscal 2015.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2015 was 43.00K shares, a 50.57% decline from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2014 was 87.00K shares, a 155.88% increase from fiscal 2013.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2013 was 34.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | 8.70K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | 112.70K shares 10-Q · filed 2020-11-20 | |||
| 2020-06-30 | 104.00K shares 10-Q/A · filed 2020-11-17 | ||||
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | 5.00K shares derived: sum of 2 quarters · filed 2020-02-14 | 7.00K shares 10-Q · filed 2020-02-14 | ||
| 2019-09-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | 7.00K shares 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | 2.00K shares 10-Q · filed 2019-08-13 | ||||
| 2018-12-31 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | 43.00K shares derived: sum of 2 quarters · filed 2019-02-14 | 48.00K shares 10-Q · filed 2019-02-14 | ||
| 2018-09-30 | 28.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | 33.00K shares 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | 5.00K shares 10-Q · filed 2018-08-08 | ||||
| 2017-12-31 | 9.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | 20.00K shares derived: sum of 2 quarters · filed 2018-02-14 | 42.00K shares 10-Q · filed 2018-02-14 | ||
| 2017-09-30 | 11.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | 33.00K shares 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | 22.00K shares 10-Q · filed 2017-08-08 | ||||
| 2016-12-31 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | 15.00K shares derived: sum of 2 quarters · filed 2017-02-17 | 16.00K shares 10-Q · filed 2017-02-17 | 138.00K shares derived: sum of 4 quarters · filed 2017-02-17 | |
| 2016-09-30 | 14.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | 15.00K shares 10-Q · filed 2016-11-15 | 137.00K shares derived: sum of 3 quarters · filed 2016-11-15 | 155.00K shares derived: sum of 4 quarters · filed 2016-11-15 | |
| 2016-06-30 | 1.00K shares 10-Q · filed 2016-08-09 | 123.00K shares derived: sum of 2 quarters · filed 2016-08-09 | 141.00K shares derived: sum of 3 quarters · filed 2016-08-09 | 138.00K shares derived: sum of 4 quarters · filed 2016-08-09 | |
| 2016-03-31 | 122.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | 140.00K shares derived: sum of 2 quarters · filed 2016-06-21 | 137.00K shares derived: sum of 3 quarters · filed 2016-06-21 | 190.00K shares 10-K · filed 2016-06-21 | |
| 2015-12-31 | 18.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | 15.00K shares derived: sum of 2 quarters · filed 2016-02-16 | 68.00K shares 10-Q · filed 2016-02-16 | ||
| 2015-09-30 | -3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-10 | 50.00K shares 10-Q · filed 2015-11-10 | |||
| 2015-06-30 | 53.00K shares 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | 43.00K shares 10-K · filed 2015-06-16 | ||||
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-12 | 3.00K shares derived: sum of 2 quarters · filed 2014-08-12 | 6.00K shares derived: sum of 3 quarters · filed 2014-08-12 | 86.95K shares derived: sum of 4 quarters · filed 2014-08-12 | |
| 2014-03-31 | 3.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | 6.00K shares derived: sum of 2 quarters · filed 2014-06-30 | 86.95K shares derived: sum of 3 quarters · filed 2014-06-30 | 87.00K shares 10-K · filed 2014-06-30 | |
| 2013-12-31 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | 83.95K shares derived: sum of 2 quarters · filed 2014-02-14 | 84.00K shares 10-Q · filed 2014-02-14 | 118.14K shares derived: sum of 4 quarters · filed 2014-06-30 | |
| 2013-09-30 | 80.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-19 | 81.00K shares 10-Q · filed 2013-11-19 | 115.14K shares derived: sum of 3 quarters · filed 2014-06-30 | ||
| 2013-06-30 | 54.00 shares 10-Q · filed 2013-08-14 | 34.19K shares derived: sum of 2 quarters · filed 2014-06-30 | |||
| 2013-03-31 | 34.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | 34.00K shares 10-K · filed 2014-06-30 | -34.00 shares 10-K · filed 2013-06-25 | ||
| 2012-12-31 | -136.00 shares 10-Q · filed 2013-02-13 | ||||
| 2012-06-30 | -61.00 shares 10-Q/A · filed 2012-08-31 | ||||
| 2012-03-31 | -24.00 shares 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |